These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 19324988)
1. Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms. Langley MR; Booker JK; Evans JP; McLeod HL; Weck KE J Mol Diagn; 2009 May; 11(3):216-25. PubMed ID: 19324988 [TBL] [Abstract][Full Text] [Related]
2. CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing. Scott SA; Jaremko M; Lubitz SA; Kornreich R; Halperin JL; Desnick RJ Pharmacogenomics; 2009 Aug; 10(8):1243-55. PubMed ID: 19663669 [TBL] [Abstract][Full Text] [Related]
3. Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose. King CR; Porche-Sorbet RM; Gage BF; Ridker PM; Renaud Y; Phillips MS; Eby C Am J Clin Pathol; 2008 Jun; 129(6):876-83. PubMed ID: 18480003 [TBL] [Abstract][Full Text] [Related]
4. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations. Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846 [TBL] [Abstract][Full Text] [Related]
5. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients. Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801 [TBL] [Abstract][Full Text] [Related]
6. Comparison of performance of three commercial platforms for warfarin sensitivity genotyping. Babic N; Haverfield EV; Burrus JA; Lozada A; Das S; Yeo KT Clin Chim Acta; 2009 Aug; 406(1-2):143-7. PubMed ID: 19545555 [TBL] [Abstract][Full Text] [Related]
7. Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping. Maurice CB; Barua PK; Simses D; Smith P; Howe JG; Stack G Clin Chim Acta; 2010 Jul; 411(13-14):947-54. PubMed ID: 20226775 [TBL] [Abstract][Full Text] [Related]
8. Genetic and clinical predictors of warfarin dose requirements in African Americans. Cavallari LH; Langaee TY; Momary KM; Shapiro NL; Nutescu EA; Coty WA; Viana MA; Patel SR; Johnson JA Clin Pharmacol Ther; 2010 Apr; 87(4):459-64. PubMed ID: 20072124 [TBL] [Abstract][Full Text] [Related]
9. Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy. Limdi NA; Wiener H; Goldstein JA; Acton RT; Beasley TM Blood Cells Mol Dis; 2009; 43(1):119-28. PubMed ID: 19297219 [TBL] [Abstract][Full Text] [Related]
10. Validation of pharmacogenetic algorithms and warfarin dosing table in Egyptian patients. Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary O Int J Clin Pharm; 2012 Dec; 34(6):837-44. PubMed ID: 22851439 [TBL] [Abstract][Full Text] [Related]
11. The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans. Perera MA; Gamazon E; Cavallari LH; Patel SR; Poindexter S; Kittles RA; Nicolae D; Cox NJ Clin Pharmacol Ther; 2011 Mar; 89(3):408-15. PubMed ID: 21270790 [TBL] [Abstract][Full Text] [Related]
12. A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms. Cini M; Legnani C; Cosmi B; Guazzaloca G; Valdrè L; Frascaro M; Palareti G Eur J Clin Pharmacol; 2012 Aug; 68(8):1167-74. PubMed ID: 22349464 [TBL] [Abstract][Full Text] [Related]
19. A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9. Tham LS; Goh BC; Nafziger A; Guo JY; Wang LZ; Soong R; Lee SC Clin Pharmacol Ther; 2006 Oct; 80(4):346-55. PubMed ID: 17015052 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of VKORC1 and CYP2C9 gene polymorphisms in Indian population and its effect on warfarin response. Shalia KK; Doshi SM; Parikh S; Pawar PP; Divekar SS; Varma SP; Mehta R; Doctor T; Shah VK; Saranath D J Assoc Physicians India; 2012 Dec; 60():34-8. PubMed ID: 23781667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]